In this context, it would be useful to carefully study, in a large prospective cohort, the dynamic of clinical features and of the immunological profile of patients presenting with pruritus and circulating autoantibodies against BP180 and/or BP230 but who do not show tissue-bound immunoreactants. The gene discussed is COL17A1; the disease is Pruritus.